SEC Form 4 · accession 0000914190-15-000263
REGENERX BIOPHARMACEUTICALS INC · RGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
R Don Elsey
Director
Period of report
Jun 30, 2015
Accepted (ET)
Jul 2, 2015 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000707511
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.36 | Jun 30, 2015 | A | 100,000 | A | — | Jun 30, 2022 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1The option vests in four equal annual installments beginning on June 30, 2015.